Press/Media
- 225 - 250 out of 817 results
Search results
-
Scientists identify new types of a blood cancer and potential targeted treatments
David Melnekoff, Joshua Richter, Samir Parekh, Violetta V. Leshchenko, Ajai Chari & Sundar Jagannath
17/11/21
1 item of Media coverage
Press/Media
-
Multiple Myeloma Patient Similarity Network Reveals Prognostically Informative Subgroups
17/11/21
2 items of Media coverage
Press/Media
-
HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration
17/11/21
8 items of Media coverage
Press/Media
-
"There is no evidence that the delta plus variant reduces the efficacy of vaccines."
11/11/21
1 item of Media coverage
Press/Media
-
Vaccinated Blood Cancer Patients Still at Risk for Severe COVID-19
9/11/21
2 items of Media coverage
Press/Media
-
‘We just have to keep pushing’: Universal flu vaccine remains out of reach, for now
Adolfo Garcia-Sastre,, Florian Krammer, & Peter Palese
3/11/21
1 item of Media coverage
Press/Media
-
CURE® Honors Oncologists, Patient Advocate in Lung Cancer Heroes® Award Program for on Impact Lung Cancer CommunityArticle
Ramon Parsons,, Matthew Galsky,, Fred Hirsch, Fred Hirsch & Kenneth Rosenzweig
29/10/21
2 items of Media coverage
Press/Media
-
Vaccines weaker than expected in multiple myeloma patients
25/10/21 → 27/10/21
3 items of Media coverage
Press/Media
-
Colin Powell's death sparks misleading claims about COVID-19 vaccines
21/10/21
1 item of Media coverage
Press/Media
-
Some Myeloma Patients Also Lack T-Cell Responses After COVID Vaccine
21/10/21
1 item of Media coverage
Press/Media
-
-
Cancer Patients With Poor Antibody Response to COVID-19 Vaccines Also Lack Secondary Immune Response, Study Shows.
19/10/21 → 20/10/21
2 items of Media coverage
Press/Media
-
Colin Powell's death sparks misleading claims about Covid-19 vaccines
19/10/21 → 20/10/21
14 items of Media coverage
Press/Media
-
Cancer Patients With Poor Antibody Response to COVID-19 Vaccines Also Lack Secondary Immune Response, Study Shows; Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now
19/10/21 → 20/10/21
5 items of Media coverage
Press/Media
-
Surge in vaccine misinformation on social media following death of Colin Powell
20/10/21
1 item of Media coverage
Press/Media
-
Colin Powell's Death Due to 'Covid Complications' Fuels Wrong Claims About Vaccines
20/10/21
1 item of Media coverage
Press/Media
-
Vaccines less protective for multiple myeloma patients; beware of fake stem cell treatment claims for COVID-19
18/10/21 → 19/10/21
10 items of Media coverage
Press/Media
-
Cancer Patients With Poor Antibody Response to COVID-19 Vaccines Also Lack Secondary Immune Response, Study Shows
18/10/21 → 19/10/21
9 items of Media coverage
Press/Media
-
-
What Scientists Know About the Risk of Breakthrough Covid Deaths
18/10/21 → 19/10/21
7 items of Media coverage
Press/Media
-
Powell was treated for cancer that severely impairs immune system, lowering vaccine effectiveness
19/10/21
1 item of Media coverage
Press/Media
-
Vaccines Less Protective for Multiple Myeloma Patients; Beware of Fake Stem Cell Treatment Claims for COVID-19
18/10/21
4 items of Media coverage
Press/Media
-
Texas Biomed scientists use ‘reporter gene’ to track how coronavirus moves through the body
13/10/21
1 item of Media coverage
Press/Media
-
Neoantigens Market Size ($10,54,783.54 Thousand by 2028) Growth Forecast at 31.2% CAGR During 2023 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
7/10/21 → 8/10/21
5 items of Media coverage
Press/Media